Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Naloxone to Reduce Opiate Overdose Deaths Raises Cost, Liability, and Safety Concerns

By Paul Kivela, MD, MBA, FACEP | on January 20, 2015 | 1 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Naloxone to Reduce Opiate Overdose Deaths Raises Cost, Liability, and Safety Concerns

A temperature-stable naloxone and intramuscular delivery device that makes an inadvertent needle stick virtually impossible has been developed. Recently, this device, called Evzio, received FDA approval.

You Might Also Like
  • Overdose Antidote Naloxone Hydrochloride Available in California Pharmacies
  • Naloxone Distribution to Patients in Emergency Department Raises Controversy
  • Georgia Joins Ranks of States Supporting Naloxone Use in Overdose Cases
Explore This Issue
ACEP Now: Vol 34 – No 01– January 2015

According to representatives of Kaléo, which makes Evzio, pricing has not been fully worked out, and there will likely be volume and institutional discounts. However, according to a New York Times article, the cost could be in the hundreds of dollars for each device.4

Sustainability

Lastly, how are first responders going to get reimbursed for medication replacement? They do not typically bill insurers or patients, and regardless, many of these patients do not have any coverage or the ability to pay.

Best Practices

With all advances come potential difficulties. Naloxone administration has the potential to save many lives. It is important to realize the potential unintended consequences so that first responders develop a program that is safe to the patient and provider, effective, and sustainable.


Dr. Kivela is managing partner at Napa Valley Emergency Medical Group, medical director of Medic Ambulance, and part owner of Elan Medical Corporation. He is Vice President of the ACEP Board of Directors.

State Naloxone Laws

There are 28 jurisdictions that have passed a naloxone law.

Key

* Prescribers immune from civil liability.
+ Lay administrator immune from civil liability.


* + California
* + Colorado
* + Connecticut
+ District Of Columbia
* Delaware
* + Georgia
Illinois
+ Kentucky
Massachusetts
Maryland
Maine
* + Michigan
* + Minnesota
* + North Carolina
* + New Jersey
* + New Mexico
+ New York
* Ohio
Oklahoma
+ Oregon
* + Pennsylvania
+ Rhode Island
* + Tennessee
* + Utah
+ Virginia
* + Vermont
Washington
* + Wisconsin

Source: LawAtlas: The Policy Surveillance Portal

References

  1. Ogbur O. Naloxone–hydrochloride injection (Narcan, Evzio). MedicineNet. Available at http://www.medicinenet.com/naloxone-injection/article.htm. Accessed Jan. 5, 2015.
  2. World Health Organization. Accelerated stability studies of widely used pharmaceutical substances under simulated tropical conditions. Available at http://apps.who.int/medicinedocs/es/d/Jh1808e. Accessed Jan. 5, 2015.
  3. Naloxone. PDR Network. Available at http://www.pdr.net/drug-summary/naloxone-hydrochloride?druglabelid=777. Accessed Jan. 5, 2015.
  4. Rosenthal E. For drugs that save lives, a steep cost. The New York Times. April 27, 2014. SR4.

Pages: 1 2 | Single Page

Topics: AddictionCritical CareDrug OverdoseEmergency DepartmentEmergency MedicineEmergency PhysicianNaloxoneOpiatePhysician SafetyPublic Health

Related

  • Opinion: Physicians Must Reduce Plastic Waste

    December 4, 2025 - 0 Comment
  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

One Response to “Naloxone to Reduce Opiate Overdose Deaths Raises Cost, Liability, and Safety Concerns”

  1. February 8, 2015

    Larry Bedard, MD Reply

    An excellent analysis by Dr. Kivela. From a cost benefit ratio it is clear that the benefit of the increased availability and use of Narcan far, far exceeds the cost of training and equipping forst responders. An opportunity for emergency physicians to provide leadership on the local and state level in addressing the opiate overdose epidemic.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603